May 2, 2026Journal of the American College of Cardiology2 citations
GW27-e1177 Semaglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca2+-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/Survivin pathways